Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-06-18

FDA Approved: CEFTRIAXONE — Supplemental Application (Baxter Healthcare Company)

View source ↗

Summary

FDA approved a supplemental application for ceftriaxone sodium (ceftriaxone) from Baxter Healthcare Company, authorizing changes to the approved generic product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

SUPPL AP for CEFTRIAXONE (CEFTRIAXONE SODIUM)